亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

供應(yīng)阿莫羅芬原料藥生產(chǎn)廠家供應(yīng)

 
 
單價(jià) 面議對(duì)比
詢價(jià) 暫無(wú)
發(fā)貨 湖北武漢市付款后3天內(nèi)
品牌 武漢大華
過(guò)期 長(zhǎng)期有效
更新 2012-10-23 14:31
 

武漢大華偉業(yè)醫(yī)藥化工公司

企業(yè)會(huì)員第14年
資料未認(rèn)證
保證金未繳納
詳細(xì)說(shuō)明

中文名稱: -2,6-二甲基-4-[2-甲基-3-(對(duì)叔戊基苯基)丙基]嗎啉

中文同義詞: 阿莫羅芬;-2,6-二甲基-4-[2-甲基-3-(對(duì)叔戊基苯基)丙基]嗎啉;(±)-2,6-二甲基-4[2-甲基-3-(對(duì)叔基苯基)丙基]嗎啉

CAS號(hào): 67467-83-8

分子式: C21H35NO

分子量: 317.51

EINECS號(hào):

相關(guān)類別:

Mol文件: 67467-83-8.mol

用途  外用抗真菌藥,與現(xiàn)有其它抗真菌藥作用機(jī)理不同,它抑制麥角甾醇生物合成中的兩個(gè)酶,還原酶和異構(gòu)化酶.體外具有極高的抗真菌活性,體內(nèi)活性優(yōu)于萘替芬、克霉唑、奧昔康唑和酮康唑,對(duì)各種真菌引起的皮膚病治愈率達(dá)85%以上,對(duì)甲癬有特效

舉報(bào)收藏 0評(píng)論 0
更多>本企業(yè)其它產(chǎn)品
供應(yīng)氨茶堿原料廠家供應(yīng) 供應(yīng)溶菌酶原料藥廠家供應(yīng) 供應(yīng)磺胺嘧啶銀原料藥廠家供應(yīng) 供應(yīng)鹽酸苯海拉明原料藥廠家供應(yīng) 供應(yīng)L-鳥氨酸鹽酸鹽廠家供應(yīng) 供應(yīng)四磷酸腺二鳥苷原料藥-生產(chǎn)廠家供應(yīng) 供應(yīng)氯雷他定原料藥廠家供應(yīng) 供應(yīng)D-泛酸鈣廠家價(jià)格
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |